Search CommunityWalk:
Create_a_map_small
Mymaps_small



Blank

General Research Laboratory, Inc.

Address:
401 Professional Drive Suite 130
--
Gaithersburg, MD, USA
1-301-740-1730

Category: BioManufacturing; Research Services & Supplies; Suppliers (CRO)

Used in the following map:

Maryland Biotech Industry Map

General Research Laboratory, Inc. (GRL) is a biopharmaceutical company focused on developing technologies to serve the pharmaceutical industry and the discovery of novel therapeutics to treat diseases and conditions related to battlefield medicine and military personnel. The company was established in 2005.

GRL holds proprietary technologies on the use of an Epoxy Encapsulated Magnetic Nanoparticle (EEMNP) system for drug delivery in oncology. The company has active programs in Whole-Genome siRNA Library (WGSL)-based high throughput screening for identification of novel drug targets and for re-invigoration of failed drugs in late stages of clinical testing. It has used the platform technologies in the identification of RNAi therapeutic candidates for treatment of prostate cancer and the improvement of wound healing. The company is actively engaged in the identification of optimal combination therapeutic regimens, including use of botanical drug candidates.

GRL is in the process of screening more than 10,000 botanical and plant extracts identified in Classic Chinese Medicine (CCM) and Ayurvedic medicine as potential botanical drug products (BDPs) for use in the treatment of diseases that are of specific importance in military medicine (battle-field Medicine) and oncology. It has active research programs in wound/bone healing, infectious diseases as well as various forms of cancer. The company plans to develop these novel therapeutic moieties for a variety of human conditions and diseases. In addition to its therapeutic formulas and molecules, the company is developing a platform for its drug discovery process that includes the application of micro-array technology to investigate the effect of BDPs on targeted disease processes.

GRL also offers services like high-throughput drug screening services and protein array services to support the drug discovery efforts of pharmaceutical and biotechnology companies.

GRL has alliance with Sirnaomics, Inc.